Reuters logo
6 months ago
BRIEF-Cancer Genetics says hereditary cancer panel selected by a global pharmaceutical company
February 16, 2017 / 1:24 PM / 6 months ago

BRIEF-Cancer Genetics says hereditary cancer panel selected by a global pharmaceutical company

Feb 16 (Reuters) - Cancer Genetics Inc

* Cancer Genetics - its hereditary cancer panel, for breast, ovarian cancer, has been selected by global pharmaceutical co for 1,000+ patient clinical study

* Cancer Genetics Inc says revenue from study will begin immediately, and company expects it to continue through 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below